Cancer‐Cell‐Specific Nuclear‐Targeted Drug Delivery by Dual‐Ligand‐Modified Mesoporous Silica Nanoparticles

Publisher: John Wiley & Sons Inc

E-ISSN: 1613-6829|11|44|5919-5926

ISSN: 1613-6810

Source: SMALL, Vol.11, Iss.44, 2015-11, pp. : 5919-5926

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract